1. Home
  2. RCKT vs CARE Comparison

RCKT vs CARE Comparison

Compare RCKT & CARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • CARE
  • Stock Information
  • Founded
  • RCKT 1999
  • CARE 1974
  • Country
  • RCKT United States
  • CARE United States
  • Employees
  • RCKT N/A
  • CARE N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • CARE Major Banks
  • Sector
  • RCKT Health Care
  • CARE Finance
  • Exchange
  • RCKT Nasdaq
  • CARE Nasdaq
  • Market Cap
  • RCKT 328.6M
  • CARE 396.9M
  • IPO Year
  • RCKT N/A
  • CARE N/A
  • Fundamental
  • Price
  • RCKT $3.28
  • CARE $19.46
  • Analyst Decision
  • RCKT Buy
  • CARE Buy
  • Analyst Count
  • RCKT 13
  • CARE 2
  • Target Price
  • RCKT $12.96
  • CARE $21.50
  • AVG Volume (30 Days)
  • RCKT 6.0M
  • CARE 71.3K
  • Earning Date
  • RCKT 08-07-2025
  • CARE 10-23-2025
  • Dividend Yield
  • RCKT N/A
  • CARE N/A
  • EPS Growth
  • RCKT N/A
  • CARE 154.06
  • EPS
  • RCKT N/A
  • CARE 1.36
  • Revenue
  • RCKT N/A
  • CARE $153,120,000.00
  • Revenue This Year
  • RCKT N/A
  • CARE $10.85
  • Revenue Next Year
  • RCKT $108.43
  • CARE $14.12
  • P/E Ratio
  • RCKT N/A
  • CARE $14.31
  • Revenue Growth
  • RCKT N/A
  • CARE 21.78
  • 52 Week Low
  • RCKT $2.19
  • CARE $13.61
  • 52 Week High
  • RCKT $22.01
  • CARE $20.40
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 51.17
  • CARE 70.53
  • Support Level
  • RCKT $2.88
  • CARE $18.42
  • Resistance Level
  • RCKT $3.74
  • CARE $19.80
  • Average True Range (ATR)
  • RCKT 0.27
  • CARE 0.43
  • MACD
  • RCKT 0.02
  • CARE 0.11
  • Stochastic Oscillator
  • RCKT 35.43
  • CARE 84.04

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About CARE Carter Bankshares Inc.

Carter Bankshares Inc is a bank holding company that conducts its business solely through the bank. The Bank earns revenue from interest on loans and securities and fees charged for financial services provided to customers. It offers a full range of deposit services including Lifetime Free Checking, interest checking accounts, savings accounts, retirement accounts and other deposit accounts of various types, ranging from money market accounts to longer-term CDs. The Bank offers a full range of commercial and consumer loans. The Bank also originates and holds fixed and variable-rate mortgage loans and offers home equity lines of credit to its customers.

Share on Social Networks: